期刊文献+

人脑胶质瘤组织P-糖蛋白的表达及其与长春新碱的药物敏感性的关系 被引量:3

The P-gp Expression in Human Glioma and Its Relevance to Primary Glioma Cells′ Vincristine Drug Sensitivity
下载PDF
导出
摘要 目的探讨细胞膜P-糖蛋白(P-gp)在人脑胶质瘤组织中的表达及原代胶质瘤细胞P-gp蛋白阳性表达与长春新碱(VCR)的敏感性的相关性。方法采用免疫组化方法检测37例人脑胶质瘤P-gp蛋白的表达;人脑胶质瘤细胞原代培养,四甲基偶氮唑蓝(MTT)比色法检测VCR药物的敏感性。结果 37例脑胶质瘤P-gp阳性表达率为54.1%(20/37),P-gp在Ⅱ~Ⅳ级脑胶质瘤的阳性表达率分别为39.4%、66.7%和87.5%。不同病理级别的胶质瘤患者P-gp阳性表达率间差异有统计学意义(χ2=8.529,P<0.05),病理级别与P-gp的表达强度呈正相关(r=0.479,P<0.05)。P-gp阳性表达与胶质瘤细胞对VCR的耐药有相关性(r=0.429,P<0.05)。结论 P-gp的表达与脑胶质瘤恶性程度及其对VCR的耐药性相关,检测P-gp的表达及其对VCR的敏感有助于指导脑胶质瘤的个体化治疗。 Objective To explore the P-gp protein expression in human glioma and its correlation with primary glioma cells′ drug sensitivity to vincristine. Methods Immunohistochemical method was used for the detection of human glioma P-gp expression in 37 cases.Primary human glioma cell was cultured,and assay vincristine(VCR) drug sensitivity was tested by methyl thiazolyl tetrazolium method(MTT). Results Of this 37 cases,positive expression of the glioma P-gp rate was 54.1%(20/37),and the rates in glioma from grade Ⅱ to Ⅳ were respectively 39.4%,66.7%,and 87.5%.Patients of different pathological grades had significantly different P-gp expressions(χ2=8.529,P0.05),and pathological grades were positively correlated to P-gp protein expression(r=0.479,P0.05).P-gp expression was relevant to glioma cells′ drug-resistance against vincristine(r=0.429,P0.05). Conclusion P-gp expression is relevant to the malignance of glioma tumors as well as the drug-resistance against vincristine.A combined detection of P-gp expression and vincristine drug sensitivity is of great value for instructing individualized therapy for glioma sufferers.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第8期859-861,共3页 Chinese General Practice
基金 河北省科技攻关计划项目(07276101D-79) 河北省2007年医学科学研究重点课题(07133)
关键词 神经胶质瘤 P-糖蛋白 微生物敏感性试验 Glioma P-glycoprotein Microbial sensitivity tests
  • 相关文献

参考文献12

二级参考文献52

  • 1李凡彩,周英琼,侯巧燕,陆明深.P-gp、GST-Л、TOPO在肺癌中的表达及意义[J].华夏医学,2005,18(1):1-5. 被引量:5
  • 2孙林泉,黄强,周丽英,李晓楠.P-糖蛋白在颅脑肿瘤中表达的研究[J].中华神经外科杂志,1996,12(2):93-95. 被引量:3
  • 3李建国,王双燕,沈若武,王守彪.血管内皮生长因子与结肠癌的相关性研究[J].山东医药,2006,46(7):42-43. 被引量:3
  • 4Nisa AU, Ahmad Z. Dubin-Johnson syndrome[ J]. J Coll Physicians Surg Pak ,2008,18 ( 3 ) : 188 - 189.
  • 5Lai Y, Xing L, Poda GI, et al. Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2) :the role of torsion angle for a series of biphenyl-substituted heterocycles[J]. Drug Metab Dispos,2007,35(6) :937 -945.
  • 6Kast HR, Goodwin B, Tarr PT, et al. Regulation of muhidrug resistance-associated protein 2 ( ABCC2 ) by the nuclearreceptors pregnane X receptor ,farnesoid X-activated receptor, and constitutive androstane receptor[ J ]. J Biol Chem, 2002,277 (4) : 2908 - 2915.
  • 7Payen L, Sparfel L, Courtois A, et al. The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds [ J]. Cell Biol Toxicol, 2002,18(4) : 221 -233.
  • 8Jedlitschky G, Hoffmann U, Kroemer HK. Structure and function of the MRP2 (ABCC2) protein and its role in drug Disposition [ J ]. Expert Opin Drug Metab Toxicol, 2006,2 ( 3 ) :351 - 366.
  • 9Mano Y, Usui T, Kamimura H. Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2[J]. Biopharm Drug Dispos, 2007, 28(1) :13 -18.
  • 10Wakamatsu T, Nakahashi Y, Hachimine D, et al. The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma ceils through inhibition of multidrug resistance-associated proteins [ J ]. Int J Oncol, 2007, 31 (6) : 1465 - 1472.

共引文献22

同被引文献26

  • 1Huang JX, Xiao W, Song ZX,et al. Expression of thymidylate synthase and glutathion--S--transferase pi in patients with e sophageal squamous cell carcinoma[J]. World J Gastroenterol, 2009,15=4316 4321.
  • 2Townsend D, Tew K. Cancer drugs, genetic variation and the glutathione--S--transferase gene family[J]. Am J pharmacog enomics, 2003,3 : 157-- 172.
  • 3Ambudkar SV, Kimchi-- Sarfaty C, Sauna ZE, Gottesman MM. P-- glycoprotein: from genomics to mechanism[J]Oncogene, 2003,22:7468 -7485.
  • 4Barad V,Paltiel O,Glatstein E. Raiotherapy for early-stage Hodgkin's lymphoma:a 21st century perspective and review of multiple randomized clinical trials[J].International Journal of Radiation Oncology,Biology,Physics,2009,(05):1472-1479.
  • 5Almeldin MA,Ellbadawy SA,Taghian AG. Breast cancer after treatment of Hodgkin's lymphoma:general review[J].InternationalJournal of Radiation Oncology Biology Physics,2009,(05):1291-1297.
  • 6Cao Al, Li Q, Yin P. Curcumin induces apoptosis inhuman gastric carcinoma AGS cells and colon carcinomaHT-29 cells through mitochondrial dysfunction and endo-plasmic reticulum stress [J]. Apoptosis, 2013,18(11): 1391 -1402.
  • 7吴学勇,张玺炜,殷晓峰,赵子仪.替莫唑胺联合放疗治疗18例初诊高级别脑胶质瘤患者的临床观察[J].中国癌症杂志,2009,19(4):288-291. 被引量:6
  • 8刘坤平,罗枫,彭辉,张婉仪,李炳权,罗丽花,赵彤.大肠癌多种耐药相关蛋白表达与预后关系的探讨[J].广东医学,2009,30(8):1081-1083. 被引量:3
  • 9董丽娟,李红影.大肠癌组织中P-gP、GST-π、bcl-2的表达变化及意义[J].山东医药,2010,50(6):105-105. 被引量:7
  • 10赵泽恩,宋琳.试论王清任活血化瘀法及其临床运用[J].内蒙古中医药,2010,29(5):40-41. 被引量:3

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部